Ayurcann Holdings Corp. (AYUR.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.71 Million CAD | 26.8% |
| 2022 | 8.67 Million CAD | 57.21% |
| 2021 | 5.51 Million CAD | 123.52% |
| 2020 | 2.46 Million CAD | 908.02% |
| 2019 | 244.77 Thousand CAD | 2.01% |
| 2018 | 239.95 Thousand CAD | -15.73% |
| 2017 | 284.74 Thousand CAD | 35.96% |
| 2016 | 209.43 Thousand CAD | -35.43% |
| 2015 | 324.33 Thousand CAD | 24.25% |
| 2014 | 261.04 Thousand CAD | -36.53% |
| 2013 | 411.26 Thousand CAD | -32.65% |
| 2012 | 610.66 Thousand CAD | 500.61% |
| 2011 | 101.67 Thousand CAD | 1395.22% |
| 2010 | 6800.00 CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 2.34 Million CAD | -40.9% |
| 2023 Q3 | 2.54 Million CAD | 2.32% |
| 2023 Q4 | 3.75 Million CAD | 47.42% |
| 2023 Q2 | 2.48 Million CAD | 6.24% |
| 2022 FY | 8.67 Million CAD | 57.21% |
| 2022 Q4 | 3.96 Million CAD | 110.39% |
| 2022 Q3 | 1.88 Million CAD | 23.84% |
| 2022 Q2 | 1.52 Million CAD | 18.46% |
| 2022 Q1 | 1.28 Million CAD | -42.89% |
| 2021 Q3 | 1.25 Million CAD | 1.36% |
| 2021 Q4 | 2.24 Million CAD | 79.18% |
| 2021 Q2 | 1.23 Million CAD | 61.94% |
| 2021 Q1 | 764.56 Thousand CAD | -11.41% |
| 2021 FY | 5.51 Million CAD | 123.52% |
| 2020 Q4 | 863.06 Thousand CAD | 3.56% |
| 2020 Q1 | 62.07 Thousand CAD | 35.75% |
| 2020 Q2 | 39.99 Thousand CAD | -35.57% |
| 2020 FY | 2.46 Million CAD | 908.02% |
| 2020 Q3 | 833.4 Thousand CAD | 1983.89% |
| 2019 FY | 244.77 Thousand CAD | 2.01% |
| 2019 Q4 | 45.72 Thousand CAD | -22.85% |
| 2019 Q3 | 59.27 Thousand CAD | -23.72% |
| 2019 Q2 | 77.7 Thousand CAD | 25.26% |
| 2019 Q1 | 62.03 Thousand CAD | 34.23% |
| 2018 Q4 | 46.21 Thousand CAD | -6.03% |
| 2018 Q3 | 49.17 Thousand CAD | -40.41% |
| 2018 Q2 | 82.53 Thousand CAD | -36.41% |
| 2018 Q1 | 129.79 Thousand CAD | 185.42% |
| 2018 FY | 239.95 Thousand CAD | -15.73% |
| 2017 Q3 | 54.14 Thousand CAD | -2.15% |
| 2017 FY | 284.74 Thousand CAD | 35.96% |
| 2017 Q4 | 45.47 Thousand CAD | -16.02% |
| 2017 Q2 | 55.33 Thousand CAD | -9.73% |
| 2017 Q1 | 61.3 Thousand CAD | 7.12% |
| 2016 Q1 | 177.2 Thousand CAD | 303.24% |
| 2016 Q3 | 43.48 Thousand CAD | -8.28% |
| 2016 Q4 | 57.23 Thousand CAD | 31.6% |
| 2016 Q2 | 47.41 Thousand CAD | -73.24% |
| 2016 FY | 209.43 Thousand CAD | -35.43% |
| 2015 FY | 324.33 Thousand CAD | 24.25% |
| 2015 Q3 | 51.27 Thousand CAD | -1.24% |
| 2015 Q4 | 43.94 Thousand CAD | -14.29% |
| 2015 Q2 | 51.91 Thousand CAD | -20.63% |
| 2015 Q1 | 65.41 Thousand CAD | 44.31% |
| 2014 Q2 | 93.4 Thousand CAD | -2.55% |
| 2014 Q3 | 56.9 Thousand CAD | -39.07% |
| 2014 Q1 | 95.84 Thousand CAD | -2.57% |
| 2014 Q4 | 45.32 Thousand CAD | -20.35% |
| 2014 FY | 261.04 Thousand CAD | -36.53% |
| 2013 Q3 | 91.17 Thousand CAD | -27.56% |
| 2013 Q2 | 125.86 Thousand CAD | -18.6% |
| 2013 Q4 | 98.38 Thousand CAD | 7.9% |
| 2013 Q1 | 154.61 Thousand CAD | 16.96% |
| 2013 FY | 411.26 Thousand CAD | -32.65% |
| 2012 Q4 | 132.19 Thousand CAD | -25.53% |
| 2012 Q3 | 177.5 Thousand CAD | 21.29% |
| 2012 Q2 | 146.34 Thousand CAD | 0.16% |
| 2012 Q1 | 146.11 Thousand CAD | 3.42% |
| 2012 FY | 610.66 Thousand CAD | 500.61% |
| 2011 FY | 101.67 Thousand CAD | 1395.22% |
| 2011 Q4 | 141.27 Thousand CAD | -56.68% |
| 2011 Q3 | 326.12 Thousand CAD | 927.57% |
| 2011 Q1 | 6974.00 CAD | -57.57% |
| 2011 Q2 | 31.73 Thousand CAD | 355.08% |
| 2010 FY | 6800.00 CAD | 0.0% |
| 2010 Q4 | 16.43 Thousand CAD | -64.67% |
| 2010 Q3 | 46.52 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -7082.698% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -13810.598% |
| The BC Bud Corporation | 1.28 Million CAD | -813.201% |
| BioNxt Solutions Inc. | 6.73 Million CAD | -73.842% |
| CordovaCann Corp. | 3.86 Million CAD | -203.403% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | -173.541% |
| Captor Capital Corp. | 16.28 Million CAD | 28.044% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -1560.203% |
| 1CM Inc. | 7.3 Million CAD | -60.322% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -2023.624% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -143.701% |
| IM Cannabis Corp. | 22.63 Million CAD | 48.245% |
| Lobe Sciences Ltd. | 4.13 Million CAD | -183.533% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -2887.181% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -19427.002% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | -562.677% |
| Ovation Science Inc. | 54.1 Thousand CAD | -21556.564% |
| Pharmadrug Inc. | 1.33 Million CAD | -777.61% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -797.513% |
| RAMM Pharma Corp. | 7.48 Million CAD | -56.625% |
| RIV Capital Inc. | 21.1 Million CAD | 44.479% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | -256.58% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 68.971% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 52.384% |
| 1933 Industries Inc. | 5.12 Million CAD | -128.598% |
| Red Light Holland Corp. | 2.02 Million CAD | -479.876% |
| Top Strike Resources Corp. | 3.63 Million CAD | -222.605% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 3898.757% |
| Adastra Holdings Ltd. | 9.36 Million CAD | -25.165% |